Background: A few months ago, the AHA (American Heart Association) task force updated their guideline on evaluating and managing patients with bradycardia. The UK Resus Council algorithm(last updated in 2015) is concise and easy to follow, but somewhat lacking in detail. The American one certainly cannot be accused of this, weighing in at 95 densely-worded pages. Luckily I was able to dive deep into this tome and bring back some gems to help us manage these patients. (Journal of the American College of Cardiology, October 2018)
Key learning points from the Task Force:
Symptomatic bradycardia is due to either sick sinus syndrome or some form of AV block
Sick sinus syndrome (aka. sinus node dysfunction – SND) encompasses a variety of conditions, including sinus bradycardia, sinoatrial exit block, sinus arrest and tachy/brady syndrome
First consider and treat reversible causes – especially hyperkalaemia or hypokalaemia but also hypoglycaemia, hypothermia, severe shock, MI and medication (beta blockers, calcium channel antagonists, digoxin, antiarrhythmics, lithium)
Trial atropine if symptomatic or unstable, unless heart transplant or wide QRS (meaning the AV block is infra-nodal so atropine won’t help)
If severe symptoms or haemodynamically unstable, pace
Indications for a permanent pacemaker are:
Irreversible, symptomatic SND
Complete heart block or at risk for developing complete heart block (Mobitz type II, any infra-nodal block, alternating LBBB and RBBB)
Expert commentary:“Remember that the ALS (Advanced Life Support) recommendations in the UK list the following 4 indications for pacemaker insertion: recent asystole, complete heart block, Mobitz type II, ventricular pauses >3 seconds.”(Dr Robert Tan, ED consultant)